Per 1,000 mL Electrolyte soln: Ca chloride dihydrate 5.145 g, Mg chloride hexahydrate 2.033 g, lactic acid 5.4 g. Buffer soln: Na bicarbonate 3.09 g, NaCl 6.45 g
Indications/Uses
Substitution soln in continuous haemofiltration & haemodiafiltration & dialysis soln in continuous haemodialysis & haemodiafiltration.
IV/for haemodialysis Individualized dosage. AdultSubstitution soln in haemofiltration & haemodiafiltration 500-3,000 mL/hr. Dialysis soln (dialysate) in continuous haemodialysis 500-2,500 mL/hr. Commonly used flow rates: Approx 2,000-2,500 mL/hr corresponding to daily fluid vol of approx 48-60 L. Childn (neonates to adolescents to 18 yr)Substitution soln in haemofiltration & haemodiafiltration for dialysis soln (dialysate) in continuous haemodialysis 1,000-2,000 mL/hr/1.73 m2. Flow rates up to 4,000 mL/hr/1.73 m2 may be needed, especially in younger childn ≤10 kg. Absolute flow rate (mL/hr) should not exceed the max adult flow rate.
Closely monitor serum K conc, electrolyte & acid-base balance, hemodynamic status & fluid balance throughout the procedure. Total K conc should not exceed 4 mEq/L (4 mmol/L) if K phosphate is added. Decrease or discontinue if metabolic alkalosis develops or worsens during therapy. May cause hypoglycemia; monitor blood glucose levels regularly. Pregnancy & lactation.
Increased risk of digitalis-induced cardiac arrhythmia during hypokalaemia. Increased risk of hypercalcemia w/ vit D & vit D analogues Ca-containing products eg, Ca chloride or Ca gluconate. Increased risk of metabolic alkalosis w/ additional Na hydrogen carbonate (or other buffer source) in continuous renal replacement therapy fluid or other fluids. Reduced plasma Ca levels w/ citrate anticoagulants.
Sign Out
